#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Pavel Aprelev Email
Director Corporate Development / Start-Up Member . Verismo Therapeutics
Philadelphia, PA
Locationp************@verismotherapeutics.com
Primary EmailHow to contact Pavel Aprelev
Join and see Pavel's contact info for free!Current Roles
Employees:
31Revenue:
$2.4MAbout
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options. Verismo Therapeutic’s core technology is built upon CARs that are uniquely engineered to more realistically reflect the natural multichain design of killer immunoglobulin-like receptors (KIRs), an important family of immunologic receptors used by T cells and NK cells. Preclinical studies show that SynKIR™-T cells, created by introducing these KIR-based CARs (KIR-CARs) into T cells, more effectively eliminate aggressive tumors in vivo when compared with T cells bearing traditional 2nd generation CAR designs found in current FDA approved CAR-T cell therapies.Verismo Therapeutics Address
3675 Market StPhiladelphia, PA
United States